All In MedTech

FDA Clearance Tracker · P000058-S002

INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 29, 2004 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 29, 2004

Approved

Time to decision

644 days

Received Oct 24, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P000058-S002
Device name
INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICE
Applicant location
Memphis, TN
Received
Oct 24, 2002
Decided
Jul 29, 2004
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P000058

Device type

Device class
Class III

Every decision under product code NEK

FDA's approval statement

As written in FDA's record.

APPROVAL FOR 1) THE EXTENSION OF THE LEVELS OF USE OF THE DEVICE FROM L4-S1 TO L2-S1 2) MODIFICATION OF THE INDICATION TO ALLOW FOR THE DEVICE TO BE USED IN SUBJECTS WHO MAY HAVE RETROLISTHESIS IN CONJUNCTION WITH DEGENERATIVE DISC DISEASE 3) CHANGE IN STORAGE TEMPERATURE LIMIT AND 4) REVISIONS TO INSTRUCTION FOR USE.

Source documents

Other decisions for Medtronic Sofamor Danek USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.